Patient Recruitment Applications & Studies
-
A Nimble And Flexible Solution To Rescuing An Observational Study
5/8/2023
Uncover how a European biotech was able to accelerate site start-up and exceed patient recruitment goals at more than 145 sites in North America, Europe, and Asia Pacific (APAC).
-
Retention Improved In A Pompe Disease Clinical Trial
4/18/2023
Explore the ways one double-blind, randomized Phase 3 study was able to boost the participant’s overall adherence to the protocol and increase their willingness to continue with the trial.
-
Recruitment Improved With Home Trial Support
3/28/2023
Discover how a complex oncology study with alternating visits between hospital, outpatient, and home was able to overcome enrollment issues.
-
NeuraLace Doubles Clinical Trial Enrollment & Improves Participant Compliance With EDC & ePRO
3/20/2023
Find out how one company dedicated to producing innovative non-invasive chronic pain therapies was able to engage its patients in new ways.
-
Supporting Enrollment Of A Phase 2 Cervical Cancer Study During A Pandemic
10/13/2022
The developer of an investigative medicinal product (IMP) for advanced, recurrent, non-resectable cervical cancer engaged Premier Research to assist with screening and enrollment in a Phase 2 study in Europe. Find out the results of this partnership.
-
Demonstrating The Impact Of The Longboat Portal On Recruitment Success
10/13/2022
A top-30 pharmaceutical company was conducting two phase 3, multicentre, randomized, double-blind studies to evaluate the safety and efficacy of a treatment for a serious dermatological condition. So how did the sites involved manage such significant and prolonged engagement?
-
How A Remote ePRO Solution Helped Reduce Patient Burden
9/19/2022
Discover how transitioning multiple studies from on-site to at-home assessments improved patient retention and recruitment for a global neurology program.
-
How A Top 3 Global CRO Reduced The Impact Of CRA Hiring And Retention Challenges
8/22/2022
Learn how a top 3 global CRO implemented technology to remotely connect with their research sites and can now monitor up to 50 sites per week, compared to the former average of two on-site monitoring visits per week.
-
Patient Diversity Case Study: RWD Solutions
7/18/2022
See how by leveraging medical claims and diversity data, this clinical trial sponsor was able to identify relevant patients meeting the trial’s I/E criteria, broken out by race and gender.
-
How We Achieved 100% Recruitment 7 Months Ahead Of Schedule
6/14/2022
Uncover how a mid-sized European contract research organization successfully completed a Phase 3 lung cancer clinical study jointly with a global CRO.